BBIO Next Earnings Date Notes

— BridgeBio Pharma (BBIO) is a clinical-stage biopharmaceutical company focused on developing innovative therapies for genetic diseases & cancers with clear genetic drivers. The company operates a unique business model that builds, acquires, and advances a diversified pipeline of more than 20 programs targeting rare and underserved conditions, ranging from enzyme deficiencies to cancers like transthyretin amyloidosis and achondroplasia. For investors tuning in to the next earnings call, it is particularly important to track the progress of lead assets such as acoramidis (for ATTR-cardiomyopathy) and infigratinib (for achondroplasia & FGFR-driven cancers), paying attention to pivotal trial timelines, regulatory milestones, and commercial launch strategies. Key business metrics include cash runway & operating expenses (to assess funding adequacy for high-cost R&D), pipeline advancement milestones (new phases, positive data readouts, and FDA submissions), and any updates on partnerships or revenue-generating deals. As BridgeBio is still pre-commercial for many programs, clinical progress and regulatory clarity are typically more relevant than current revenue figures in assessing its long-term success & potential shareholder value. The next projected earnings date for BBIO is 8/4/2026 after close (stay tuned for a confirmed earnings date once announced).

BBIO Next Earnings Date FAQ

On this page we presented the BBIO Next Earnings Date information for BridgeBio Pharma along with recent past earnings dates. For Q1 of 2026, BBIO reported earnings of -0.840/share, with the earnings report taking place on 5/7/2026. For Q4 of 2025, BBIO reported earnings of -1.000/share, with the earnings report taking place on 2/24/2026. For Q3 of 2025, BBIO reported earnings of -0.950/share, with the earnings report taking place on 10/29/2025. For Q2 of 2025, BBIO reported earnings of -0.950/share, with the earnings report taking place on 8/5/2025. For Q1 of 2025, BBIO reported earnings of -0.880/share, with the earnings report taking place on 4/29/2025. Based on these past earnings dates, the projected next earnings date for BBIO is 8/4/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as BridgeBio Pharma. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to BridgeBio Pharma shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research BridgeBio Pharma next earnings dates as well as any other stock out there in our coverage universe, to see when the next BBIO earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up BBIO's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the BBIO next earnings date.